Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-21 Sale |
2021-05-25 08:41 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
40,000 | $11.01 | $440,320 | 33,128 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 07:48 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,884 | $10.22 | $387,125 | 2,974 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 07:45 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
19,066 | $10.22 | $194,830 | 92,272 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 07:44 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
19,804 | $10.22 | $202,413 | 73,128 (Direct) |
View |
| 2021-03-16 Sale |
2021-03-17 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
127,244 | $11.22 | $1,427,614 | 20,598 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $10.57 | $147,186 | 111,633 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
19,608 | $10.56 | $207,091 | 161,994 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $10.58 | $136,909 | 25,870 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
9,515 | $10.57 | $100,536 | 206,322 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
6,183 | $10.58 | $65,443 | 169,232 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
6,012 | $10.57 | $63,523 | 205,646 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-08 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
7,513 | $10.58 | $79,521 | 142,425 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
15,548 | $10.85 | $168,631 | 15,571 (Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
1,400 | $10.88 | $15,231 | 0 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
50,000 | $10.82 | $540,890 | 64,064 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-14 Option Award |
2021-06-16 08:12 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:10 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
25,791 | $0 | 25,791 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 08:12 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Peres Nechemia Jacob Director |
12,668 | $0 | 44,286 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:47 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
12,668 | $0 | 12,668 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:46 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
12,668 | $0 | 36,330 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:45 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
12,668 | $0 | 44,286 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:43 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
12,668 | $0 | 1,544,286 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:42 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
12,668 | $0 | 54,628 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:41 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Halfon Jean Michel Director |
12,668 | $0 | 49,228 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:40 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
12,668 | $0 | 2,042,934 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:39 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
12,668 | $0 | 52,218 (Direct) |
View |
| 2021-06-09 Exercise |
2021-06-10 07:39 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
22,565 | $0 | 317,563 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 08:19 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
6,041 | $0 | 39,550 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:32 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
6,041 | $0 | 23,662 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:30 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Peres Nechemia Jacob Director |
6,041 | $0 | 31,618 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:30 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
6,041 | $0 | 31,618 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:29 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
6,041 | $0 | 1,531,618 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:27 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
6,041 | $0 | 41,960 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:26 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Halfon Jean Michel Director |
6,041 | $0 | 36,560 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:25 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
6,041 | $0 | 2,030,266 (Direct) |
View |
| 2021-06-05 Exercise |
2021-06-08 07:23 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
17,565 | $0 | 294,998 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:48 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,884 | $0 | 2,974 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:46 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
37,884 | $0 | 58,482 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:45 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
37,884 | $0 | 92,272 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 07:44 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
37,884 | $0 | 73,128 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
80,798 | $0 | 111,633 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
13,930 | $0 | 111,633 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
285,171 | $0 | 1,265,156 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
59,701 | $0 | 1,265,156 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
95,057 | $0 | 274,740 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" below |
15,920 | $0 | 274,740 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
109,315 | $0 | 161,994 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
18,905 | $0 | 161,994 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $0 | 25,870 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
12,935 | $0 | 25,870 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
85,551 | $0 | 85,551 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
95,057 | $0 | 206,322 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
18,905 | $0 | 206,322 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
90,304 | $0 | 169,232 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
11,940 | $0 | 169,232 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
99,809 | $0 | 205,646 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP Global Marketing&Portfolio |
13,930 | $0 | 205,646 (Direct) |
View |
| 2021-03-05 Option Award |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
90,304 | $0 | 142,425 (Direct) |
View |
| 2021-03-04 Exercise |
2021-03-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
15,920 | $0 | 142,425 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | O'Grady Brendan P. EVP, North America Commercial |
1,166 | $0 | 15,571 (Direct) |
View |
| 2021-03-03 Exercise |
2021-03-04 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nazzi Gianfranco EVP, International Markets |
1,400 | $0 | 0 (Direct) |
View |